In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1039-1045

  Kern, Earl R ^a,c   Kushner, Nicole L ^a   Hartline, Caroll B ^a   Williams Aziz, Stephanie L ^a   Harden, Emma A ^a   Zhou, Shaoman ^b   Zemlicka, Jiri ^b   Prichard, Mark N ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAVIR; CYCLOPROPANE DERIVATIVE; CYCLOPROPAVIR; NUCLEOSIDE DERIVATIVE; PHOSPHOTRANSFERASE; TETRAZOLIUM; UNCLASSIFIED DRUG; VIRUS DNA; ZSM I 62;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DNA SYNTHESIS; DOT HYBRIDIZATION; DRUG EFFICACY; DRUG MECHANISM; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; IN VITRO STUDY; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; GANCICLOVIR; HERPESVIRIDAE; NUCLEOSIDES; VIRUS REPLICATION;

EID: 14744273965     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1039-1045.2005     Document Type: Article

References (25)

1. Baldanti, F., A. Sarasini, J. C. Drach, J. Zemlicka, and G. Gerna. 2002. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants. Antiviral Res. 56:273-278.
2. Bidanset, D. J., C. B. Hartline, D. J. Collins, D. C. Quenelle, Y. Chen, J. Zemlicka, and E. R. Kern. 2002. In vitro and in vivo activity of the methylenecyclopropane analogs Qyl-1064, against murine and human cytomegalovirus infection. Antiviral Res. 53:A61.
3. Biron, K. K., R. J. Harvey, S. C. Chamberlain, S. S. Good, A. A. Smith III, M. G. Davis, C. L. Talarico, W. H. Miller, R. Ferris, R. E. Dornsife, S. C. Stanat, J. C. Drach, L. B. Townsend, and G. W. Koszalka. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46:2365-2372.
4. Boivin, G., C. Gilbert, A. Gaudreau, I. Greenfield, R. Sudlow, and N. A. Roberts. 2001. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis. J. Infect. Dis. 184:1598-1602.
5. Britt, W. A., and C. A. Alford. 2001. Cytomegalovirus, p. 2493-2523. In B. N. Fields, D. M. Knipe, P. M. Howley, and D. E. Griffin (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
6. Chen, X., E. R. Kern, J. C. Drach, E. Gullen, Y. C. Cheng, and J. Zemlicka. 2003. Structure-activity relationships of (S,Z)-2-aminopurine methylenecyclopropane analogues of nucleosides. Variation of purine-6 substituents and activity against herpesviruses and hepatitis B virus. J. Med. Chem. 46:1531-1537.
7. Chou, S., N. S. Lurain, K. D. Thompson, R. C. Miner, and W. L. Drew. 2003. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J. Infect. Dis. 188:32-39.
8. Kern, E. R., D. J. Bidanset, C. B. Hartline, Z. Yan, J. Zemlicka, and D. C. Quenelle. 2004. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections. Antimicrob. Agents Chemother. 48:4745-4753.
9. Kern, E. R., J. C. Overall, Jr., and L. A. Glasgow. 1973. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J. Infect. Dis. 128:290-299.
10. Kushner, N. L., S. L. Williams, C. B. Hartline, E. A. Harden, D. J. Bidanset, X. Chen, J. Zemlicka, and E. R. Kern. 2003. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro. Nucleosides Nucleotides Nucleic Acids 22:2105-2119.
11. Landolfo, S., M. Gariglio, G. Gribaudo, and D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
12. Long, M. C., D. J. Bidanset, S. L. Williams, N. L. Kushner, and E. R. Kern. 2003. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry. Antiviral Res. 58:149-157.
13. Prichard, M. N., G. M. Duke, and E. S. Mocarski. 1996. Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol. 70:3018-3025.
14. Prichard, M. N., N. Gao, S. Jairath, G. Mulamba, P. Krosky, D. M. Coen, B. O. Parker, and G. S. Pari. 1999. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J. Virol. 73:5663-5670.
15. Prichard, M. N., and C. Shipman, Jr. 1990. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 14:181-205.
16. Qiu, Y. L., F. Geiser, T. Kira, E. Gullen, Y. C. Cheng, R. G. Ptak, J. M. Breitenbach, J. C. Drach, C. B. Hartline, E. R. Kern, and J. Zemlicka. 2000. Synthesis and enantioselectivity of the antiviral effects of (R,Z)-,(S,Z)-methylenecyclopropane analogues of purine nucleosides and phosphoralaninate prodrugs: influence of heterocyclic base, type of virus and host cells. Antivir. Chem. Chemother. II:191-202.
17. Qiu, Y. L., M. B. Ksebati, R. G. Ptak, B. Y. Fan, J. M. Breitenbach, J. S. Lin, Y. C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. J. Med. Chem. 41:10-23.
18. Qiu, Y. L., R. G. Ptak, J. M. Breitenbach, J. S. Lin, Y. C. Cheng, J. C. Drach, E. R. Kern, and J. Zemlicka. 1999. Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues of nucleosides. Antiviral Res. 43:37-53.
19. Qiu, Y. L., R. G. Ptak, J. M. Breitenbach, J. S. Lin, Y. C. Cheng, E. R. Kern, J. C. Drach, and J. Zemlicka. 1998. (Z)- and (E)-2- (hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Antivir. Chem. Chemother. 9:341-352.
20. Rybak, R. J., C. B. Hartline, Y. L. Qiu, J. Zemlicka, E. Harden, G. Marshall, J. P. Sommadossi, and E. R. Kern. 2000. In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate pro-drugs against cytomegalovirus and other herpesvirus infections. Antimicrob. Agents Chemother. 44:1506-1511.
21. Rybak, R. J., J. Zemlicka, Y. L. Qiu, C. B. Hartline, and E. R. Kern. 1999. Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides. Antiviral Res. 43:175-188.
22. Williams, S. L., C. B. Hartline, N. L. Kushner, E. A. Harden, D. J. Bidanset, J. C. Drach, L. B. Townsend, M. R. Underwood, K. K. Biron, and E. R. Kern. 2003. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrob. Agents Chemother. 47:2186-2192.
23. Zemlicka, J. 1993. Allenols derived from nucleic acid bases - a new class of anti-HIV agents: chemistry and biological activity, p. 73-100. In C. K. Chu and D. C. Baker (ed.), Nucleosides and nucleotides as antitumor and antiviral agents. Plenum Press, New York, N.Y.
24. Zemlicka, J. 2002. Unusual analogues of nucleosides: chemistry and biological activity, p. 327-357. In C. K. Chu (ed.), Recent advances in nucleosides: chemistry and chemotherapy. Elsevier, Amsterdam, The Netherlands.
25. Zhou, S., J. M. Breitenbach, K. Z. Borysko, J. C. Drach, E. R. Kern, E. Gullen, Y. C. Cheng, and J. Zemlicka. 2004. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. J. Med. Chem. 47:566-575.